

Publisher: Karger
E-ISSN: 1664-5553|2|1|16-24
ISSN: 2235-1795
Source: Liver Cancer, Vol.2, Iss.1, 2013-01, pp. : 16-24
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content


Epidemiological Trends of Hepatocellular Carcinoma in Austria
Digestive Diseases, Vol. 32, Iss. 6, 2014-10 ,pp. :


Sorafenib for Hepatocellular Carcinoma: From Randomized Controlled Trials to Clinical Practice
Digestive Diseases, Vol. 33, Iss. 5, 2015-09 ,pp. :


Chemoembolization in Patients with Hepatocellular Carcinoma
Liver Cancer, Vol. 1, Iss. 1, 2012-06 ,pp. :

